Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S, Murakami N, Takahashi K, Kuno I, Takayanagi D, Asami Y, Matsuda M, Shimada Y, Yamano S, Sunami K, Yoshida K, Honda T, Nakahara T, Watanabe T, Komatsu M, Hamamoto R, Kato MK, Matsumoto K, Okuma K, Kuroda T, Okamoto A, Itami J, Kohno T, Kato T, Shiraishi K, Yoshida H.
Hirose S, et al. Among authors: hamamoto r.
Gynecol Oncol. 2020 Jan;156(1):203-210. doi: 10.1016/j.ygyno.2019.10.022. Epub 2019 Nov 19.
Gynecol Oncol. 2020.
PMID: 31757465